Grants and Contributions:
Title:
Development of glycoconjugate vaccines for the livestock industry
Agreement Number:
901798
Agreement Value:
$135,000.00
Agreement Date:
Apr 1, 2018 - Mar 31, 2019
Description:
Bacterial infections in livestock have animal health, human health and financial impacts. We will identify, characterize and exploit bacterial surface glycans to develop vaccines against veterinary bacterial pathogens, positively impacting the livestock industry.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6R 2J8
Reference Number:
172-2018-2019-Q1-901798
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
802863043
Recipient Type:
For-profit organization
Recipient's Operating Name:
VaxAlta Inc.
Recipient's Legal Name:
VaxAlta Inc.
Federal Riding Name:
Edmonton Riverbend
Federal Riding Number:
48018
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710